| scholarly article | Q13442814 |
| P2093 | author name string | Carolin Tonus | |
| Gero Neupert | |||
| Markus Sellinger | |||
| P2860 | cites work | One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. | Q55035114 |
| Multiple detection of genetic alterations in tumors and stool | Q73738348 | ||
| Hypoxia-inducible factor 1: master regulator of O2 homeostasis | Q77485489 | ||
| Detection of proximal colorectal cancers through analysis of faecal DNA | Q77639048 | ||
| A simple method of detecting K-ras point mutations in stool samples for colorectal cancer screening using one-step polymerase chain reaction/restriction fragment length polymorphism analysis | Q77732501 | ||
| A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population | Q81013919 | ||
| Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells | Q24528249 | ||
| Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer | Q24645339 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK) | Q28143504 | ||
| The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma | Q28143510 | ||
| Tumor type M2 pyruvate kinase expression in advanced breast cancer | Q28186200 | ||
| Quantitative detection of tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases | Q28200358 | ||
| Pyruvate kinase type M2 and its role in tumor growth and spreading | Q28252131 | ||
| Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls | Q28263391 | ||
| Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma | Q28267942 | ||
| Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas | Q28277917 | ||
| Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer | Q28283765 | ||
| Randomised controlled trial of faecal-occult-blood screening for colorectal cancer | Q29999461 | ||
| Pyruvate kinase M2 (tumor M2-PK) as a screening tool for colorectal cancer (CRC). A review of current published data | Q33228043 | ||
| Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7. | Q34099933 | ||
| Immunohistological demonstration of the same type of pyruvate kinase isoenzyme (M2-Pk) in tumors of chicken and rat | Q34246408 | ||
| Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. | Q34342590 | ||
| American Cancer Society guidelines for the early detection of cancer, 2006. | Q36383102 | ||
| Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel | Q38463506 | ||
| Detecting colorectal cancer in stool with the use of multiple genetic targets | Q39569642 | ||
| Hypoxia regulates beta-enolase and pyruvate kinase-M promoters by modulating Sp1/Sp3 binding to a conserved GC element | Q42461521 | ||
| Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls | Q44486909 | ||
| A comparison of fecal occult-blood tests for colorectal-cancer screening | Q45001270 | ||
| Faecal pyruvate kinase type M2--a valid screening parameter for colorectal cancer? Preliminary results from a multicenter comparative study | Q45020822 | ||
| Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia | Q46854314 | ||
| Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. | Q50638892 | ||
| Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL-ethionine-supplemented diet. | Q53437107 | ||
| P433 | issue | 43 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | feces | Q496 |
| biomarker | Q864574 | ||
| colorectal cancer | Q188874 | ||
| colorectal cancer screening | Q19391980 | ||
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 7007-7011 | |
| P577 | publication date | 2006-11-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK. | |
| P478 | volume | 12 |
| Q38427493 | A systematic review and meta-analysis of the diagnostic accuracy of pyruvate kinase M2 isoenzymatic assay in diagnosing colorectal cancer. |
| Q36316592 | Advances in gas chromatographic methods for the identification of biomarkers in cancer. |
| Q28080279 | Colorectal Cancer Screening in Average Risk Populations: Evidence Summary |
| Q46569204 | Comparison of an established simple office-based immunological FOBT with fecal tumor pyruvate kinase type M2 (M2-PK) for colorectal cancer screening: prospective multicenter study |
| Q36865592 | Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy |
| Q37977312 | Diagnostic value of fecal tumor M2-pyruvate kinase for CRC screening: a systematic review and meta-analysis |
| Q38357717 | Early detection of colorectal cancer: from conventional methods to novel biomarkers |
| Q24616985 | Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: a meta-analysis |
| Q36948688 | Faecal screening of colorectal cancer |
| Q42846847 | Fecal tumor M2 pyruvate kinase is not a specific biomarker for colorectal cancer screening |
| Q37817114 | Gastrointestinal fluids proteomics. |
| Q54645375 | Plasma TM2-PK levels in mycosis fungoides patients |
| Q47890629 | Protein levels of clusterin and glutathione synthetase in platelets allow for early detection of colorectal cancer. |
| Q37805757 | Review of biomarkers in colorectal cancer |
| Q36755160 | Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening study |
| Q36056889 | Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening |
| Q35687171 | The Diagnostic Accuracy of the M2 Pyruvate Kinase Quick Stool Test--A Rapid Office Based Assay Test for the Detection of Colorectal Cancer |
| Q36037152 | The Usefulness of a Novel Screening Kit for Colorectal Cancer Using the Immunochromatographic Fecal Tumor M2 Pyruvate Kinase Test |
| Q33740788 | The discovery and validation of colorectal cancer biomarkers |
| Q92091601 | Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer |
Search more.